Use of alpelisib in the treatment of hormone receptor positive metastatic breast cancer: An institutional experience.

被引：0
|
作者：
Tamang, Tsering G. Lama
Kyung, Daniel
Eisenbud, Lauren
Tang, Tianyi
Parajuli, Ritesh
Mehta, Rita S.
机构：
[1] Univ Calif Orange, Orange, CA USA
[2] UCI, Hematol Oncol Div, Orange, CA USA
[3] Univ Miami, Sylvester Comp Ctr, Coral Gables, FL USA
[4] Univ Calif Irvine, Med Ctr, Orange, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15216
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Real world outcomes with alpelisib in metastatic hormone receptor-positive breast cancer patients: A single institution experience
    Alaklabi, Sabah
    Roy, Arya Mariam
    Attwood, Kristopher
    George, Anthony
    O'Connor, Tracey
    Early, Amy
    Levine, Ellis G.
    Gandhi, Shipra
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [2] Palbociclib in hormone positive metastatic breast cancer: A real world multicenter Indian experience.
    Rauthan, Amit
    Patil, Poonam
    Somashekhar, S. P.
    Jacob, Linu Abraham
    Lokanatha, D.
    Kumar, Kishore
    Keechilat, Pavithran
    Vijayakumar, D. K.
    Patil, Shekar
    Shashidhara, H. P.
    Zaveri, Shabber
    Yashas, Nitin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Everolimus plus exemestane for hormone resistant metastatic breast cancer (MBC): A single institutional experience.
    Foltran, Luisa
    Bertola, Manuela
    Del Conte, Alessandro
    Lo Re, Giovanni
    Bestetti, Alessandro
    Sandri, Paolo
    Saracchini, Silvana
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] Alpelisib for the treatment of PIK3CA-mutated, hormone receptor-positive, HER2-negative metastatic breast cancer
    Leenhardt, Fanny
    Alexandre, Marie
    Jacot, William
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (06) : 667 - 675
  • [5] Everolimus and exemestane in hormone receptor-positive advanced breast cancer: A comprehensive cancer center's experience.
    Moreira, Ines
    Ferreira, Marta
    Afonso, Ana
    Ferreira, Ana
    Rodrigues, Ana
    Vieira, Claudia
    Oliveira, Cristina
    Savva-Bordalo, Joana
    Dias, Joao
    Cassiano, Maria
    Abreu, Miguel
    Alves, Sara
    Sousa, Susana
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [6] Everolimus in metastatic hormone-receptor positive Breast Cancer
    Richter-Ehrenstein, C.
    [J]. ONKOLOGE, 2012, 18 (05): : 435 - +
  • [7] Real world experience of palbociclib in hormone receptor-positive metastatic breast cancer.
    Malik, Faizan
    Ali, Naveed
    Jafri, Syed Imran Mustafa
    Sundermeyer, Mark L.
    Seidman, Michael Jeffrey
    Fidler, Christian Joseph
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] PALBOCICLIB IN THE TREATMENT OF METASTATIC BREAST CANCER. INSTITUTIONAL EXPERIENCE
    Mainella, A.
    Vigo, S.
    Marmissolle, F.
    Price, P.
    Sansano, M.
    Lujan, M. L.
    Dominguez, M. P.
    Zapata Caamano, G.
    Menna, E.
    Giacomi, N.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A624 - A624
  • [9] Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer
    Ahrong Ham
    Min Hwan Kim
    Gun Min Kim
    Jee Hung Kim
    Jee Ye Kim
    Hyung Seok Park
    Seho Park
    Young Up Cho
    Byeong Woo Park
    Seung Il Kim
    Joohyuk Sohn
    [J]. Breast Cancer Research and Treatment, 2020, 183 : 107 - 116
  • [10] Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer
    Ham, Ahrong
    Kim, Min Hwan
    Kim, Gun Min
    Kim, Jee Hung
    Kim, Jee Ye
    Park, Hyung Seok
    Park, Seho
    Cho, Young Up
    Park, Byeong Woo
    Kim, Seung Il
    Sohn, Joohyuk
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2020, 183 (01) : 107 - 116
12345